In the news

Medtronic CEO Geoff Martha joins ‘The Claman Countdown’ to discuss the company’s Q4 earnings results and why the company is separating its diabetes business.

Ahead of Mother’s Day, Star Jones is partnering with Medtronic for their “Letter to My Mother” campaign to encourage women to discuss the importance of heart health.

Medtronic Endoflip™ helped doctors diagnose Jessica Herrala with achalasia, a rare swallowing disorder affecting roughly 1 in 100,000 people.

Dr. Sally Saba, chief global inclusion and diversity officer at Medtronic and president of the Medtronic Foundation, joins the Work in Progress podcast to discuss the organization’s new Spark initiative.

The new adaptive device, BrainSense™, is the result of decades of research into reading changes in brain signals and developing algorithms that can respond to those changes in real time.

Medtronic CEO Geoff Martha shares his perspective on the company’s dual commitment to patients and performance.

Established in 1997, the Visible Heart Laboratory helps Medtronic test lifesaving technology while training the next generation.

Kevin Hill is one of the earliest patients to benefit from adaptive deep brain stimulation. After years of sleepless nights and being unable to manage the uncontrollable shaking of his arm and leg, his tremors "stopped instantly.”

Medtronic CEO Geoff Martha joins Jim Cramer for a conversation about the company’s product pipeline, including new innovations in Parkinson’s treatment.

Molly Young’s doctors used Medtronic StealthStation™ navigation to map her brain, safely removing 95% of her tumor.